Brenda Libby Coleman

Array ( [id] => 5829412 [patent_doc_number] => 20060063927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-23 [patent_title] => 'Processes for preparing quetiapine and salts thereof' [patent_app_type] => utility [patent_app_number] => 11/229678 [patent_app_country] => US [patent_app_date] => 2005-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7049 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20060063927.pdf [firstpage_image] =>[orig_patent_app_number] => 11229678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 386680 [patent_doc_number] => 07304049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-12-04 [patent_title] => 'Succinoylaminobenzodiazepines as inhibitors of Aβ protein production' [patent_app_type] => utility [patent_app_number] => 11/230203 [patent_app_country] => US [patent_app_date] => 2005-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44324 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/304/07304049.pdf [firstpage_image] =>[orig_patent_app_number] => 11230203 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5794069 [patent_doc_number] => 20060014750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Pharmaceutical compositions for the treatment of CNS and other disorders' [patent_app_type] => utility [patent_app_number] => 11/228449 [patent_app_country] => US [patent_app_date] => 2005-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26212 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014750.pdf [firstpage_image] =>[orig_patent_app_number] => 11228449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726868 [patent_doc_number] => 20060057628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof' [patent_app_type] => utility [patent_app_number] => 11/225095 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2825 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057628.pdf [firstpage_image] =>[orig_patent_app_number] => 11225095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5231369 [patent_doc_number] => 20070293477 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-20 [patent_title] => 'Novel Compounds' [patent_app_type] => utility [patent_app_number] => 11/574761 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17692 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20070293477.pdf [firstpage_image] =>[orig_patent_app_number] => 11574761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740826 [patent_doc_number] => 20080234479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Novel Process For Preparation of a Pharmaceutically Pure Polymorphic Form I of Olanzapine' [patent_app_type] => utility [patent_app_number] => 11/568422 [patent_app_country] => US [patent_app_date] => 2005-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2104 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234479.pdf [firstpage_image] =>[orig_patent_app_number] => 11568422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123077 [patent_doc_number] => 07704990 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Agents for preventing and treating disorders involving modulation of the RyR receptors' [patent_app_type] => utility [patent_app_number] => 11/212413 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 22 [patent_no_of_words] => 29575 [patent_no_of_claims] => 120 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704990.pdf [firstpage_image] =>[orig_patent_app_number] => 11212413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705719 [patent_doc_number] => 20060194767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Novel agents for preventing and treating disorders involving modulation of the RyR receptors' [patent_app_type] => utility [patent_app_number] => 11/212309 [patent_app_country] => US [patent_app_date] => 2005-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 29847 [patent_no_of_claims] => 267 [patent_no_of_ind_claims] => 46 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194767.pdf [firstpage_image] =>[orig_patent_app_number] => 11212309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5801418 [patent_doc_number] => 20060035883 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Novel serotonin receptor ligands and their uses thereof' [patent_app_type] => utility [patent_app_number] => 11/202628 [patent_app_country] => US [patent_app_date] => 2005-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8404 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20060035883.pdf [firstpage_image] =>[orig_patent_app_number] => 11202628 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5131608 [patent_doc_number] => 20070208005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'TETRAHYDROBENZAZEPINES AS ANTAGONISTS AND/OR REVERSE AGONISTS OF THE HISTAMINE H3 RECEPTOR' [patent_app_type] => utility [patent_app_number] => 11/573732 [patent_app_country] => US [patent_app_date] => 2005-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26108 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20070208005.pdf [firstpage_image] =>[orig_patent_app_number] => 11573732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5211001 [patent_doc_number] => 20070249585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Triazolobenzodiazepines and Their Use as Vasopressin Antagonists' [patent_app_type] => utility [patent_app_number] => 11/570694 [patent_app_country] => US [patent_app_date] => 2005-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15399 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249585.pdf [firstpage_image] =>[orig_patent_app_number] => 11570694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591465 [patent_doc_number] => 20060040917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Benzoxazepine derivatives as selective estrogen receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/191499 [patent_app_country] => US [patent_app_date] => 2005-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8008 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040917.pdf [firstpage_image] =>[orig_patent_app_number] => 11191499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591467 [patent_doc_number] => 20060040919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Bronchorelaxing compounds' [patent_app_type] => utility [patent_app_number] => 11/186841 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 28659 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040919.pdf [firstpage_image] =>[orig_patent_app_number] => 11186841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728352 [patent_doc_number] => 20080207896 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Process For the Manufacture of Mirtazapine' [patent_app_type] => utility [patent_app_number] => 11/630505 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4298 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207896.pdf [firstpage_image] =>[orig_patent_app_number] => 11630505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5769221 [patent_doc_number] => 20060019943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Homopiperidine derivatives as NK-1 antagonists' [patent_app_type] => utility [patent_app_number] => 11/183691 [patent_app_country] => US [patent_app_date] => 2005-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8811 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20060019943.pdf [firstpage_image] =>[orig_patent_app_number] => 11183691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875272 [patent_doc_number] => 20060166968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Crystalline form of oxcarbazepine' [patent_app_type] => utility [patent_app_number] => 11/182352 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2176 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166968.pdf [firstpage_image] =>[orig_patent_app_number] => 11182352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4619380 [patent_doc_number] => 07999100 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-16 [patent_title] => 'Method for chiral inversion of (S)-(+)-and (R)-(−)-10,11-dihydro-10-hydroxy-5H-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof' [patent_app_type] => utility [patent_app_number] => 11/572077 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4095 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/999/07999100.pdf [firstpage_image] =>[orig_patent_app_number] => 11572077 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4797895 [patent_doc_number] => 20080009481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-10 [patent_title] => 'Process For Making Form I Of Olanzapine' [patent_app_type] => utility [patent_app_number] => 11/572081 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2302 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20080009481.pdf [firstpage_image] =>[orig_patent_app_number] => 11572081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 64425 [patent_doc_number] => 07759484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'Mixed solvate of olanzapine, method for preparing it and method for preparing form I of olanzapine therefrom' [patent_app_type] => utility [patent_app_number] => 11/568021 [patent_app_country] => US [patent_app_date] => 2005-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 2742 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/759/07759484.pdf [firstpage_image] =>[orig_patent_app_number] => 11568021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7597619 [patent_doc_number] => 07618958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects' [patent_app_type] => utility [patent_app_number] => 11/173981 [patent_app_country] => US [patent_app_date] => 2005-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 52294 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/618/07618958.pdf [firstpage_image] =>[orig_patent_app_number] => 11173981 [rel_patent_id] =>[rel_patent_doc_number] =>)